The effect of two iso-caloric meals containing equal amounts of fats with a different fat composition on the inflammatory and metabolic markers in apparently healthy volunteers

Journal of Inflammation (United Kingdom)

Volumn 10, Issue 1, 2013, Pages

  Raz, Olga ^a,c   Steinvil, Arie ^b   Berliner, Shlomo ^b   Rosenzweig, Tovit ^c   Justo, Dan ^b   Shapira, Itzhak ^b  

^a TEL AVIV SOURASKY MEDICAL CENTER   (Israel)

^b TEL AVIV UNIVERSITY   (Israel)

^c ARIEL UNIVERSITY   (Israel)

Author keywords

Inflammation; Monounsaturated fats; Nutrition; Saturated fat

Indexed keywords

BIOLOGICAL MARKER; C REACTIVE PROTEIN; FIBRINOGEN; GLUCOSE; INSULIN; INTERCELLULAR ADHESION MOLECULE 1; INTERLEUKIN 6; TRIACYLGLYCEROL; TUMOR NECROSIS FACTOR; VASCULAR CELL ADHESION MOLECULE 1;

ANALYSIS OF VARIANCE; ARTICLE; ENDOTHELIUM; ENZYME IMMUNOASSAY; ERYTHROCYTE SEDIMENTATION RATE; FOOD INTAKE; GENETIC VARIABILITY; HOMEOSTASIS MODEL ASSESSMENT; HUMAN; HUMAN EXPERIMENT; HYPERTRIGLYCERIDEMIA; INFLAMMATION; INSULIN RESISTANCE; LEUKOCYTE COUNT; LIPID COMPOSITION; NORMAL HUMAN; PROTEIN BLOOD LEVEL;

EID: 84873048324     PISSN: None     EISSN: 14769255     Source Type: Journal    
DOI: 10.1186/1476-9255-10-3     Document Type: Article

References (64)

1. Gasteyger C, Tremblay A: Metabolic impact of body fat distribution. J Endocrinol Invest 2002, 25:876-883.
2. Diamant M, Lamb HJ, van de Ree MA, Endert EL, Groeneveld Y, Bots ML, Kostense PJ, Radder JK: The association between abdominal visceral fat and carotid stiffness is mediated by circulating inflammatory markers in uncomplicated type 2 diabetes. J Clin Endocrinol Metab 2005, 90:1495-1501.
3. Piche ME, Lemieux S, Weisnagel SJ, Corneau L, Nadeau A, Bergeron J: Relation of high-sensitivity C-reactive protein, interleukin-6, tumor necrosis factor-alpha, and fibrinogen to abdominal adipose tissue, blood pressure, and cholesterol and triglyceride levels in healthy postmenopausal women. Am J Cardiol 2005, 96:92-97.
4. Despres JP, Lemieux I, Prud'homme D: Treatment of obesity: need to focus on high risk abdominally obese patients. BMJ 2001, 322:716-720.
5. Grundy SM, Brewer HB Jr, Cleeman JI, Smith SC Jr, Lenfant C: Definition of metabolic syndrome: Report of the National Heart, Lung, and Blood Institute/American Heart Association conference on scientific issues related to definition. Circulation 2004, 109:433-438.
6. Chrysohoou C, Panagiotakos DB, Pitsavos C, Das UN, Stefanadis C: Adherence to the Mediterranean diet attenuates inflammation and coagulation process in healthy adults: The ATTICA Study. J Am Coll Cardiol 2004, 44:152-158.
7. Digenio AG, Mancuso JP, Gerber RA, Dvorak RV: Comparison of methods for delivering a lifestyle modification program for obese patients: a randomized trial. Ann Intern Med 2009, 150:255-262.
8. Lavi T, Karasik A, Koren-Morag N, Kanety H, Feinberg MS, Shechter M: The acute effect of various glycemic index dietary carbohydrates on endothelial function in nondiabetic overweight and obese subjects. J Am Coll Cardiol 2009, 53:2283-2287.
9. Raitakari M, Ilvonen T, Ahotupa M, Lehtimaki T, Harmoinen A, Suominen P, Elo J, Hartiala J, Raitakari OT: Weight reduction with very-low-caloric diet and endothelial function in overweight adults: role of plasma glucose. Arterioscler Thromb Vasc Biol 2004, 24:124-128.
10. Shai I, Schwarzfuchs D, Henkin Y, Shahar DR, Witkow S, Greenberg I, Golan R, Fraser D, Bolotin A, Vardi H, et al: Weight loss with a low-carbohydrate, Mediterranean, or low-fat diet. N Engl J Med 2008, 359:229-241.
11. Dandona P, Aljada A, Chaudhuri A, Mohanty P, Garg R: Metabolic syndrome: a comprehensive perspective based on interactions between obesity, diabetes, and inflammation. Circulation 2005, 111:1448-1454.
12. Hotamisligil GS, Peraldi P, Budavari A, Ellis R, White MF, Spiegelman BM: IRS-1-mediated inhibition of insulin receptor tyrosine kinase activity in TNF-alpha- and obesity-induced insulin resistance. Science 1996, 271:665-668.
13. Hotamisligil GS, Shargill NS, Spiegelman BM: Adipose expression of tumor necrosis factor-alpha: direct role in obesity-linked insulin resistance. Science 1993, 259:87-91.
14. Axelsen M, Smith U, Eriksson JW, Taskinen MR, Jansson PA: Postprandial hypertriglyceridemia and insulin resistance in normoglycemic first-degree relatives of patients with type 2 diabetes. Ann Intern Med 1999, 131:27-31.
15. Cardona F, Morcillo S, Gonzalo-Marin M, Tinahones FJ: The apolipoprotein E genotype predicts postprandial hypertriglyceridemia in patients with the metabolic syndrome. J Clin Endocrinol Metab 2005, 90:2972-2975.
16. Charlesworth JA, Kriketos AD, Jones JE, Erlich JH, Campbell LV, Peake PW: Insulin resistance and postprandial triglyceride levels in primary renal disease. Metabolism 2005, 54:821-828.
17. Eliasson B, Mero N, Taskinen MR, Smith U: The insulin resistance syndrome and postprandial lipid intolerance in smokers. Atherosclerosis 1997, 129:79-88.
18. Eriksson JW, Buren J, Svensson M, Olivecrona T, Olivecrona G: Postprandial regulation of blood lipids and adipose tissue lipoprotein lipase in type 2 diabetes patients and healthy control subjects. Atherosclerosis 2003, 166:359-367.
19. Halkes CJ, Van Wijk JP, Ribalta J, Masana L, Castro Cabezas M: Diurnal triglyceridaemia and insulin resistance in mildly obese subjects with normal fasting plasma lipids. J Intern Med 2004, 255:74-81.
20. Hwu CM, Kwok CF, Kuo CS, Hsiao LC, Lee YS, Wei MJ, Kao WY, Lee SH, Ho LT: Exacerbation of insulin resistance and postprandial triglyceride response in newly diagnosed hypertensive patients with hypertriglyceridaemia. J Hum Hypertens 2002, 16:487-493.
21. Karamanos BG, Thanopoulou AC, Roussi-Penesi DP: Maximal post-prandial triglyceride increase reflects post-prandial hypertriglyceridaemia and is associated with the insulin resistance syndrome. Diabet Med 2001, 18:32-39.
22. Taskinen MR: Insulin resistance and lipoprotein metabolism. Curr Opin Lipidol 1995, 6:153-160.
23. van Wijk JP, Halkes CJ, Erkelens DW, Castro Cabezas M: Fasting and daylong triglycerides in obesity with and without type 2 diabetes. Metabolism 2003, 52:1043-1049.
24. Matthews DR, Hosker JP, Rudenski AS, Naylor BA, Treacher DF, Turner RC: Homeostasis model assessment: insulin resistance and beta-cell function from fasting plasma glucose and insulin concentrations in man. Diabetologia 1985, 28:412-419.
25. Chen H, Sullivan G, Quon MJ: Assessing the predictive accuracy of QUICKI as a surrogate index for insulin sensitivity using a calibration model. Diabetes 2005, 54:1914-1925.
26. Muniyappa R, Lee S, Chen H, Quon MJ: Current approaches for assessing insulin sensitivity and resistance in vivo: advantages, limitations, and appropriate usage. Am J Physiol Endocrinol Metab 2008, 294:E15-E26.
27. Lam TK, Leung DT: More on simplified calculation of body-surface area. N Engl J Med 1988, 318:1130.
28. Mosteller RD: Simplified calculation of body-surface area. N Engl J Med 1987, 317:1098.
29. Health TI: M.o. Tzameret; 2009. cited; Available from: http://www.health.gov.il/pages/default.asp?maincat=33&catId=749.
30. Clauss A: Gerinnungsphysiologische Schnellmethode zur Bestimmung des Fibrinogens. Acta Haematol Basel 1957, 17:237-246.
31. Rifai N, Tracy RP, Ridker PM: Clinical efficacy of an automated high-sensitivity C-reactive protein assay. Clin Chem 1999, 45:2136-2141.
32. Esposito K, Nappo F, Marfella R, Giugliano G, Giugliano F, Ciotola M, Quagliaro L, Ceriello A, Giugliano D: Inflammatory cytokine concentrations are acutely increased by hyperglycemia in humans: role of oxidative stress. Circulation 2002, 106:2067-2072.
33. Nappo F, Esposito K, Cioffi M, Giugliano G, Molinari AM, Paolisso G, Marfella R, Giugliano D: Postprandial endothelial activation in healthy subjects and in type 2 diabetic patients: role of fat and carbohydrate meals. J Am Coll Cardiol 2002, 39:1145-1150.
34. Carroll MF, Schade DS: Timing of antioxidant vitamin ingestion alters postprandial proatherogenic serum markers. Circulation 2003, 108:24-31.
35. Jenkins DJ, Kendall CW, Marchie A, Faulkner DA, Wong JM, de Souza R, Emam A, Parker TL, Vidgen E, Lapsley KG, et al: Effects of a dietary portfolio of cholesterol-lowering foods vs lovastatin on serum lipids and C-reactive protein. JAMA 2003, 290:502-510.
36. Liu S, Manson JE, Buring JE, Stampfer MJ, Willett WC, Ridker PM: Relation between a diet with a high glycemic load and plasma concentrations of high-sensitivity C-reactive protein in middle-aged women. Am J Clin Nutr 2002, 75:492-498.
37. Pischon T, Hankinson SE, Hotamisligil GS, Rifai N, Willett WC, Rimm EB: Habitual dietary intake of n-3 and n-6 fatty acids in relation to inflammatory markers among US men and women. Circulation 2003, 108:155-160.
38. Riserus U, Basu S, Jovinge S, Fredrikson GN, Arnlov J, Vessby B: Supplementation with conjugated linoleic acid causes isomer-dependent oxidative stress and elevated C-reactive protein: a potential link to fatty acid-induced insulin resistance. Circulation 2002, 106:1925-1929.
39. Esposito K, Marfella R, Ciotola M, Di Palo C, Giugliano F, Giugliano G, D'Armiento M, D'Andrea F, Giugliano D: Effect of a mediterranean-style diet on endothelial dysfunction and markers of vascular inflammation in the metabolic syndrome: a randomized trial. JAMA 2004, 292:1440-1446.
40. Ceriello A, Assaloni R, Da Ros R, Maier A, Piconi L, Quagliaro L, Esposito K, Giugliano D: Effect of atorvastatin and irbesartan, alone and in combination, on postprandial endothelial dysfunction, oxidative stress, and inflammation in type 2 diabetic patients. Circulation 2005, 111:2518-2524.
41. Seshadri P, Iqbal N, Stern L, Williams M, Chicano KL, Daily DA, McGrory J, Gracely EJ, Rader DJ, Samaha FF: A randomized study comparing the effects of a low-carbohydrate diet and a conventional diet on lipoprotein subfractions and C-reactive protein levels in patients with severe obesity. Am J Med 2004, 117:398-405.
42. Tannock LR, O'Brien KD, Knopp RH, Retzlaff B, Fish B, Wener MH, Kahn SE, Chait A: Cholesterol feeding increases C-reactive protein and serum amyloid A levels in lean insulin-sensitive subjects. Circulation 2005, 111:3058-3062.
43. Biasucci LM: CDC/AHA Workshop on Markers of Inflammation and Cardiovascular Disease: Application to Clinical and Public Health Practice: clinical use of inflammatory markers in patients with cardiovascular diseases: a background paper. Circulation 2004, 110:e560-e567.
44. Libby P, Ridker PM: Inflammation and atherosclerosis: role of C-reactive protein in risk assessment. Am J Med 2004, 116(Suppl 6A):9S-16S.
45. Ridker PM: Cardiology Patient Page. C-reactive protein: a simple test to help predict risk of heart attack and stroke. Circulation 2003, 108:e81-e85.
46. Parikh P, McDaniel MC, Ashen MD, Miller JI, Sorrentino M, Chan V, Blumenthal RS, Sperling LS: Diets and cardiovascular disease: an evidence-based assessment. J Am Coll Cardiol 2005, 45:1379-1387.
47. Ursini F, Zamburlini A, Cazzolato G, Maiorino M, Bon GB, Sevanian A: Postprandial plasma lipid hydroperoxides: a possible link between diet and atherosclerosis. Free Radic Biol Med 1998, 25:250-252.
48. Masson CJ, Mensink RP: Exchanging saturated fatty acids for (n-6) polyunsaturated fatty acids in a mixed meal may decrease postprandial lipemia and markers of inflammation and endothelial activity in overweight men. J Nutr 2011, 141:816-821.
49. Sjoholm A, Nystrom T: Endothelial inflammation in insulin resistance. Lancet 2005, 365:610-612.
50. Labarrere CA, Zaloga GP: C-reactive protein: from innocent bystander to pivotal mediator of atherosclerosis. Am J Med 2004, 117:499-507.
51. Pepys MB, Hirschfield GM: C-reactive protein: a critical update. J Clin Invest 2003, 111:1805-1812.
52. Ridker PM, Buring JE, Cook NR, Rifai N: C-reactive protein, the metabolic syndrome, and risk of incident cardiovascular events: an 8-year followup of 14 719 initially healthy American women. Circulation 2003, 107:391-397.
53. Fu T, Borensztajn J: Macrophage uptake of low-density lipoprotein bound to aggregated C-reactive protein: possible mechanism of foam-cell formation in atherosclerotic lesions. Biochem J 2002, 366:195-201.
54. Jarvisalo MJ, Harmoinen A, Hakanen M, Paakkunainen U, Viikari J, Hartiala J, Lehtimaki T, Simell O, Raitakari OT: Elevated serum C-reactive protein levels and early arterial changes in healthy children. Arterioscler Thromb Vasc Biol 2002, 22:1323-1328.
55. Poppitt SD, Keogh GF, Lithander FE, Wang Y, Mulvey TB, Chan YK, McArdle BH, Cooper GJ: Postprandial response of adiponectin, interleukin-6, tumor necrosis factor-alpha, and C-reactive protein to a high-fat dietary load. Nutrition 2008, 24:322-329.
56. Wood LG, Garg ML, Gibson PG: A high-fat challenge increases airway inflammation and impairs bronchodilator recovery in asthma. J Allergy Clin Immunol 2011, 127:1133-1140.
57. Boquist S, Ruotolo G, Tang R, Bjorkegren J, Bond MG, de Faire U, Karpe F, Hamsten A: Alimentary lipemia, postprandial triglyceride-rich lipoproteins, and common carotid intima-media thickness in healthy, middle-aged men. Circulation 1999, 100:723-728.
58. Erridge C, Attina T, Spickett CM, Webb DJ: A high-fat meal induces low-grade endotoxemia: evidence of a novel mechanism of postprandial inflammation. Am J Clin Nutr 2007, 86:1286-1292.
59. van Oostrom AJ, Rabelink TJ, Verseyden C, Sijmonsma TP, Plokker HW, De Jaegere PP, Cabezas MC: Activation of leukocytes by postprandial lipemia in healthy volunteers. Atherosclerosis 2004, 177:175-182.
60. Ferreira AC, Peter AA, Mendez AJ, Jimenez JJ, Mauro LM, Chirinos JA, Ghany R, Virani S, Garcia S, Horstman LL, et al: Postprandial hypertriglyceridemia increases circulating levels of endothelial cell microparticles. Circulation 2004, 110:3599-3603.
61. Igarashi M, Hirata A, Yamauchi T, Yamaguchi H, Tsuchiya H, Ohnuma H, Jimbu Y, Okuyama Y, Shirata T, Otsu N, et al: Clinical utility and approach to estimate postprandial hypertriglycemia by a newly designed oral fat-loading test. J Atheroscler Thromb 2003, 10:314-320.
62. Marz W, Scharnagl H, Winkler K, Tiran A, Nauck M, Boehm BO, Winkelmann BR: Low-density lipoprotein triglycerides associated with low-grade systemic inflammation, adhesion molecules, and angiographic coronary artery disease: the Ludwigshafen Risk and Cardiovascular Health study. Circulation 2004, 110:3068-3074.
63. Tirosh A, Rudich A, Shochat T, Tekes-Manova D, Israeli E, Henkin Y, Kochba I, Shai I: Changes in triglyceride levels and risk for coronary heart disease in young men. Ann Intern Med 2007, 147:377-385.
64. Kathiresan S, Larson MG, Vasan RS, Guo CY, Gona P, Keaney JF Jr, Wilson PW, Newton-Cheh C, Musone SL, Camargo AL, et al: Contribution of clinical correlates and 13 C-reactive protein gene polymorphisms to interindividual variability in serum C-reactive protein level. Circulation 2006, 113:1415-1423.